Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy

被引:74
作者
Bunch, T. Jared [1 ]
Munger, Thomas M. [1 ]
Friedman, Paul A. [1 ]
Asirvatham, Samuel J. [1 ]
Brady, Peter A. [1 ]
Cha, Yong-Mei [1 ]
Rea, Robert F. [1 ]
Shen, Win-Kuang [1 ]
Powell, Brian D. [1 ]
Ommen, Steve R. [1 ]
Monahan, Kristi H. [1 ]
Haroldson, Janis M. [1 ]
Packer, Douglas L. [1 ]
机构
[1] St Marys Hosp, Mayo Clin, Heart Rhythm Serv, Dept Internal Med,Div Cardiovasc Dis, Rochester, MN 55902 USA
关键词
catheter ablation; atrial fibrillation; hypertrophic cardiomyopathy; heart atrium; diastole;
D O I
10.1111/j.1540-8167.2008.01192.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Substrate and Procedural Predictors of Outcome in Patients with Hypertrophic Cardiomyopathy. Background: Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established. Methods: Thirty-three consecutive patients (25 male, age 51 +/- 11 years) with HCM underwent pulmonary vein (PV) isolation (n = 8) or wide area circumferential ablation with additional linear ablation (n = 25) for drug-refractory AF. Twelve-lead and 24-hour ambulating ECGs, echocardiograms, event monitor strips, and SF 36 quality of life (QOL) surveys were obtained before ablation and for routine follow-up. Results: Twenty-one (64%) patients had paroxysmal AF and 12 (36%) had persistent/permanent AF for 6.2 +/- 5.2 years. The average ejection fraction was 0.63 +/- 0.12. The average left atrial volume index was 70 +/- 24 mL/m(2). Over a follow-up of 1.5 +/- 1.2 years, 1-year survival with AF elimination was 62%(Confidence Interval [CI]: 66-84) and with AF control was 75%(CI: 66-84). AF control was less likely in patients with a persistent/chronic AF, larger left atrial volumes, and more advanced diastolic disease. Additional linear ablation may improve outcomes in patient with severe left atrial enlargement and more advanced diastolic dysfunction. Two patients had a periprocedureal TIA, one PV stenosis, and one died after mitral valve replacement from prosthetic valve thrombosis. QOL scores improved from baseline at 3 and 12 months. Conclusion: Outcomes after AF ablation in patients with HCM are favorable. Diastolic dysfunction, left atrial enlargement, and AF subtype influence outcomes. Future studies of rhythm management approaches in HCM patients are required to clarify the optimal clinical approach.
引用
收藏
页码:1009 / 1014
页数:6
相关论文
共 23 条
  • [1] VALIDATING THE SF-36 HEALTH SURVEY QUESTIONNAIRE - NEW OUTCOME MEASURE FOR PRIMARY CARE
    BRAZIER, JE
    HARPER, R
    JONES, NMB
    OCATHAIN, A
    THOMAS, KJ
    USHERWOOD, T
    WESTLAKE, L
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1992, 305 (6846): : 160 - 164
  • [2] Prognostic significance of exercise induced arrhythmias and echocardiographic variables in hypertrophic cardiomyopathy
    Bunch, T. Jared
    Chandrasekaran, Krishnaswamy
    Ehrsam, Jo-Ellen
    Hammill, Stephen C.
    Urban, Lynn H.
    Hodge, David O.
    Ommen, Steve R.
    Pellikka, Patricia A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (06) : 835 - 838
  • [3] Callans DJ, 2006, CIRCULATION, V114, P704
  • [4] Effects of omapatrilat on cardiac nerve sprouting and structural remodeling in experimental congestive heart failure
    Cha, YM
    Redfield, MM
    Shah, S
    Shen, WK
    Fishbein, MC
    Chen, PS
    [J]. HEART RHYTHM, 2005, 2 (09) : 984 - 990
  • [5] Quality-of-life in patients with paroxysmal atrial fibrillation after catheter ablation: Results of long-term follow-up
    Erdogan, A
    Carlsson, J
    Neumann, T
    Berkowitsch, A
    Neuzner, J
    Hamm, CW
    Pitschner, HF
    [J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (03): : 678 - 684
  • [6] Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
    Gaita, Fiorenzo
    Di Donna, Paolo
    Olivotto, Iacopo
    Scaglione, Marco
    Ferrero, Ivana
    Montefusco, Antonio
    Caponi, Domenico
    Conte, Maria Rosa
    Nistri, Stefano
    Cecchi, Franco
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11) : 1575 - 1581
  • [7] GLANCY DL, 1970, BRIT HEART J, V32, P652
  • [8] Gruver EJ, 1999, AM J CARDIOL, V83, p13H
  • [9] Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy
    Kiticaslan, F
    Verma, A
    Saad, E
    Themistoctakis, S
    Bonso, A
    Raviele, A
    Bozbas, H
    Andrews, MW
    Beheiry, S
    Hao, S
    Cummings, JE
    Marrouche, NF
    Lakkireddy, D
    Wazni, O
    Yamaji, H
    Saenz, LC
    Saliba, W
    Schweikert, RA
    Natale, A
    [J]. HEART RHYTHM, 2006, 3 (03) : 275 - 280
  • [10] Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
    Lang, RM
    Bierig, M
    Devereux, RB
    Flachskampf, FA
    Foster, E
    Pellikka, PA
    Picard, MH
    Roman, MJ
    Seward, J
    Shanewise, JS
    Solomon, SD
    Spencer, KT
    Sutton, MS
    Stewart, WJ
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2005, 18 (12) : 1440 - 1463